These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

4518 related items for PubMed ID: 29923514

  • 1. Whole-body 18F-fluorodeoxyglucose positron emission tomography-computed tomography (18F-FDG PET/CT) for staging locally advanced breast cancer: A prospective study from a tertiary cancer centre in south India.
    Gajjala SR, Hulikal N, Kadiyala S, Kottu R, Kalawat T.
    Indian J Med Res; 2018 Mar; 147(3):256-262. PubMed ID: 29923514
    [Abstract] [Full Text] [Related]

  • 2. Impact of Pretreatment Combined (18)F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography Staging on Radiation Therapy Treatment Decisions in Locally Advanced Breast Cancer.
    Ng SP, David S, Alamgeer M, Ganju V.
    Int J Radiat Oncol Biol Phys; 2015 Sep 01; 93(1):111-7. PubMed ID: 26279029
    [Abstract] [Full Text] [Related]

  • 3. 18F-FDG PET/CT in staging patients with locally advanced or inflammatory breast cancer: comparison to conventional staging.
    Groheux D, Giacchetti S, Delord M, Hindié E, Vercellino L, Cuvier C, Toubert ME, Merlet P, Hennequin C, Espié M.
    J Nucl Med; 2013 Jan 01; 54(1):5-11. PubMed ID: 23213197
    [Abstract] [Full Text] [Related]

  • 4. The role of (18)F-FDG PET/CT in initial staging of patients with locally advanced breast carcinoma with an emphasis on M staging.
    Mittal BR, Manohar K, Kashyap R, Bhattacharya A, Singh B, Singh G.
    Hell J Nucl Med; 2011 Jan 01; 14(2):135-9. PubMed ID: 21761015
    [Abstract] [Full Text] [Related]

  • 5. Role of 18F-FDG PET/CT in identifying distant metastatic disease missed by conventional imaging in patients with locally advanced breast cancer.
    Manohar K, Mittal BR, Bhoil A, Bhattacharya A, Singh G.
    Nucl Med Commun; 2013 Jun 01; 34(6):557-61. PubMed ID: 23549551
    [Abstract] [Full Text] [Related]

  • 6. Utility of [18F] Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography (FDG PET/CT) in the Initial Staging and Response Assessment of Locally Advanced Breast Cancer Patients Receiving Neoadjuvant Chemotherapy.
    Hulikal N, Gajjala SR, Kalawat TC, Kottu R, Amancharla Yadagiri L.
    Indian J Surg Oncol; 2015 Dec 01; 6(4):330-6. PubMed ID: 27065657
    [Abstract] [Full Text] [Related]

  • 7. Clinical utility of F-18 FDG PET/CT in recurrent breast carcinoma.
    Manohar K, Mittal BR, Senthil R, Kashyap R, Bhattacharya A, Singh G.
    Nucl Med Commun; 2012 Jun 01; 33(6):591-6. PubMed ID: 22334135
    [Abstract] [Full Text] [Related]

  • 8. Staging PET-CT Scanning Provides Superior Detection of Lymph Nodes and Distant Metastases than Traditional Imaging in Locally Advanced Breast Cancer.
    Garg PK, Deo SV, Kumar R, Shukla NK, Thulkar S, Gogia A, Sharma DN, Mathur SR.
    World J Surg; 2016 Aug 01; 40(8):2036-42. PubMed ID: 27220508
    [Abstract] [Full Text] [Related]

  • 9. [18F]Fluorodeoxyglucose (FDG)-Positron Emission Tomography (PET)/Computed Tomography (CT) in Suspected Recurrent Breast Cancer: A Prospective Comparative Study of Dual-Time-Point FDG-PET/CT, Contrast-Enhanced CT, and Bone Scintigraphy.
    Hildebrandt MG, Gerke O, Baun C, Falch K, Hansen JA, Farahani ZA, Petersen H, Larsen LB, Duvnjak S, Buskevica I, Bektas S, Søe K, Jylling AM, Ewertz M, Alavi A, Høilund-Carlsen PF.
    J Clin Oncol; 2016 Jun 01; 34(16):1889-97. PubMed ID: 27001573
    [Abstract] [Full Text] [Related]

  • 10. Fluorine-18-fluorodeoxyglucose (FDG) positron emission tomography (PET) computed tomography (CT) for the detection of bone, lung, and lymph node metastases in rhabdomyosarcoma.
    Vaarwerk B, Breunis WB, Haveman LM, de Keizer B, Jehanno N, Borgwardt L, van Rijn RR, van den Berg H, Cohen JF, van Dalen EC, Merks JH.
    Cochrane Database Syst Rev; 2021 Nov 09; 11(11):CD012325. PubMed ID: 34753195
    [Abstract] [Full Text] [Related]

  • 11. 18F-2-fluoro-2-deoxy-d-glucose positron emission tomography in staging of locally advanced breast cancer.
    van der Hoeven JJ, Krak NC, Hoekstra OS, Comans EF, Boom RP, van Geldere D, Meijer S, van der Wall E, Buter J, Pinedo HM, Teule GJ, Lammertsma AA.
    J Clin Oncol; 2004 Apr 01; 22(7):1253-9. PubMed ID: 15051773
    [Abstract] [Full Text] [Related]

  • 12. (18)F-FDG-PET/CT for systemic staging of newly diagnosed triple-negative breast cancer.
    Ulaner GA, Castillo R, Goldman DA, Wills J, Riedl CC, Pinker-Domenig K, Jochelson MS, Gönen M.
    Eur J Nucl Med Mol Imaging; 2016 Oct 01; 43(11):1937-44. PubMed ID: 27129866
    [Abstract] [Full Text] [Related]

  • 13. ¹⁸F-Fluorodeoxyglucose positron emission tomography/computed tomography finds answers in cancer patients with increasing tumor markers and negative or equivocal conventional imaging modalities.
    Salem SS, Shahin MA.
    Nucl Med Commun; 2012 Mar 01; 33(3):313-21. PubMed ID: 22237387
    [Abstract] [Full Text] [Related]

  • 14. Added value of pretreatment (18)F-FDG PET/CT for staging of advanced gastric cancer: Comparison with contrast-enhanced MDCT.
    Kawanaka Y, Kitajima K, Fukushima K, Mouri M, Doi H, Oshima T, Niwa H, Kaibe N, Sasako M, Tomita T, Miwa H, Hirota S.
    Eur J Radiol; 2016 May 01; 85(5):989-95. PubMed ID: 27130061
    [Abstract] [Full Text] [Related]

  • 15. F-18 fluorodeoxyglucose positron-emission tomography in the diagnosis of tumor recurrence and metastases in the follow-up of patients with breast carcinoma: a comparison to conventional imaging.
    Gallowitsch HJ, Kresnik E, Gasser J, Kumnig G, Igerc I, Mikosch P, Lind P.
    Invest Radiol; 2003 May 01; 38(5):250-6. PubMed ID: 12750613
    [Abstract] [Full Text] [Related]

  • 16. ¹⁸F-FDG-PET/CT in staging, restaging, and treatment response assessment of male breast cancer.
    Groheux D, Hindié E, Marty M, Espié M, Rubello D, Vercellino L, Bousquet G, Ohnona J, Toubert ME, Merlet P, Misset JL.
    Eur J Radiol; 2014 Oct 01; 83(10):1925-33. PubMed ID: 24985086
    [Abstract] [Full Text] [Related]

  • 17. Factors affecting the accuracy of 18F-FDG PET/CT in evaluating axillary metastases in invasive breast cancer.
    Kutluturk K, Simsek A, Comak A, Gonultas F, Unal B, Kekilli E.
    Niger J Clin Pract; 2019 Jan 01; 22(1):63-68. PubMed ID: 30666022
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. 18F-FDG PET/CT as a staging procedure in primary stage II and III breast cancer: comparison with conventional imaging techniques.
    Koolen BB, Vrancken Peeters MJ, Aukema TS, Vogel WV, Oldenburg HS, van der Hage JA, Hoefnagel CA, Stokkel MP, Loo CE, Rodenhuis S, Rutgers EJ, Valdés Olmos RA.
    Breast Cancer Res Treat; 2012 Jan 01; 131(1):117-26. PubMed ID: 21935602
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 226.